Literature DB >> 3612660

Autologous blood transfusion in elective orthopaedic surgery.

S E James, M A Smith.   

Abstract

Autologous blood transfusion is one of the most effective ways of avoiding the need for homologous transfusion and all its associated complications. Since the beginning of 1985, autotransfusions have been used in 48 patients undergoing total joint replacement, without significant complications. Their average haemoglobin level two weeks postoperatively was 11.3 mg/dl. We believe that this is a safe, effective and economical procedure which benefits both patients and medical staff, and its use should be more widespread.

Entities:  

Mesh:

Year:  1987        PMID: 3612660      PMCID: PMC1290809          DOI: 10.1177/014107688708000508

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  6 in total

1.  The use of banked autologous blood in total hip replacement surgery.

Authors:  T H Mallory; M Kennedy
Journal:  Clin Orthop Relat Res       Date:  1976-06       Impact factor: 4.176

2.  Banked autologous blood in total hip replacement.

Authors:  L Marmor; D Berkus; J D Robertson; J Wilson; K A Meeske
Journal:  Surg Gynecol Obstet       Date:  1977-07

3.  Autotransfusion in children's orthopaedics.

Authors:  H R Cowell; J W Swickard
Journal:  J Bone Joint Surg Am       Date:  1974-07       Impact factor: 5.284

4.  Autologous blood transfusion in pulmonary surgery.

Authors:  W Q Ascari; P C Jolly; P A Thomas
Journal:  Transfusion       Date:  1968 Mar-Apr       Impact factor: 3.157

5.  Transfusion-associated AIDS--a cause for concern.

Authors:  J R Bove
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

6.  Safety of autologous blood donation prior to elective surgery for a variety of potentially "high-risk" patients.

Authors:  M Mann; H J Sacks; D Goldfinger
Journal:  Transfusion       Date:  1983 May-Jun       Impact factor: 3.157

  6 in total
  1 in total

1.  Autologous blood transfusion.

Authors:  G N Smith
Journal:  J R Soc Med       Date:  1987-09       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.